Therapeutic trials comparing angiotensin converting enzyme inhibitors and angiotensin II receptor blockers

WJ Elliott - Current Hypertension Reports, 2000 - Springer
Two independent pharmacologic methods of specifically interfering with the renin-
angiotensin-aldosterone system have been brought to the marketplace: angiotensin …
被引用次数：47 相关文章

Therapeutic trials comparing angiotensin converting enzyme inhibitors and Angiotensin II receptor blockers

WJ Elliott - Current Hypertension Reports, 2000 - infona.pl
Two independent pharmacologic methods of specifically interfering with the renin-
angiotensin-aldosterone system have been brought to the marketplace: angiotensin …

Therapeutic trials comparing angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.

WJ Elliott - Current Hypertension Reports, 2000 - europepmc.org
Two independent pharmacologic methods of specifically interfering with the renin-
angiotensin-aldosterone system have been brought to the marketplace: angiotensin …

Therapeutic trials comparing angiotensin converting enzyme inhibitors and Angiotensin II receptor blockers

WJ Elliott - Current Hypertension Reports, 2000 - search.proquest.com
Two independent pharmacologic methods of specifically interfering with the renin-
angiotensin-aldosterone system have been brought to the marketplace: angiotensin …

Therapeutic trials comparing angiotensin converting enzyme inhibitors and angiotensin II receptor blockers

WJ Elliott - Current hypertension reports, 2000 - pubmed.ncbi.nlm.nih.gov
Two independent pharmacologic methods of specifically interfering with the renin-
angiotensin-aldosterone system have been brought to the marketplace: angiotensin …

[引用][C] Therapeutic trials comparing angiotensin converting enzyme inhibitors and Angiotensin II receptor blockers

WJ Elliott - Current Hypertension Reports, 2000 - Springer